Friese was recruited to join the faculty at the
University of Michigan's School of Nursing in 2008. Friese also wrote a research paper which was cited by the IOM Future of Nursing 2008 report in their recommendation to increase the proportion of registered nurses who hold a BSN. and as a member of the Governing Board of the Patient-Centered Outcomes Research Institute in 2018. From 2016 to 2017, with support from a grant from the Robert Wood Johnson Foundation, Friese completed a one-year health policy fellowship at the National Academy of Medicine and the Office of United States Senator
Robert P. Casey, Jr. In 2017, Friese was appointed the inaugural Elizabeth Tone Hosmer Professor of Nursing. During the
COVID-19 pandemic, Friese and colleague
Bhramar Mukherjee were named the new associate directors for cancer control and population sciences and cancer data sciences, respectively, at the Rogel Cancer Center. As the pandemic grew across the world, he participated in the
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study. Friese also published findings of another study which highlighted the need to improve reporting and training, and for additional research into the underlying causes of hazardous spills. In October 2020, Friese was elected to membership in the
National Academy of Medicine. In 2021, the Oncology Nursing Society named Friese as the recipient of the organization's distinguished researcher award. President Biden appointed Friese to a six-year term on the National Cancer Advisory Board, which advises the federal government on national cancer research policy. In 2022, Friese was inducted into the Sigma Theta Tau International Nurse Researcher Hall of Fame. Friese assumed the role of Vice Provost for Academic and Faculty Affairs at the University of Michigan on June 1, 2024, while also maintaining his faculty appointment. ==References==